Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ADPT
ADPT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ADPT News
Adaptive Biotechnologies Officer Plans to Sell $4.66 Million in Common Stock via Form 144
Mar 02 2026
moomoo
Adaptive Biotechnologies Stock Rating Upgraded
Feb 21 2026
Yahoo Finance
Adaptive Biotechnologies Reports Strong Q4 2025 Earnings Growth and Positive Outlook
Feb 06 2026
seekingalpha
Adaptive Biotechnologies to Announce Q4 Earnings on February 5th
Feb 04 2026
seekingalpha
Adaptive Biotechnologies Reports 55% Revenue Growth to $277 Million for FY 2025
Jan 13 2026
Benzinga
Planet Labs PBC Secures Nine-Figure Deal with Swedish Armed Forces, Shares Surge 7%
Jan 12 2026
Benzinga
Adaptive Biotechnologies Reports $72M Q4 Revenue, 43% Increase in ClonoSEQ Tests
Jan 12 2026
NASDAQ.COM
Adaptive Biotechnologies Reports 55% Revenue Growth to $277 Million in 2025
Jan 12 2026
Globenewswire
Adaptive Biotechnologies to Present at 44th J.P. Morgan Healthcare Conference
Dec 30 2025
Globenewswire
Adaptive Biotechnologies Leads Life Sciences Tools and Services Stocks in Year-to-Date Performance
Dec 23 2025
SeekingAlpha
Options Trading for Adaptive Biotechnologies (ADPT) in the First Week of February 2026
Dec 19 2025
NASDAQ.COM
Pfizer and Merck Return to Stability, Attracting 2026 Investors Once More
Dec 17 2025
Benzinga
Analyst Predicts Another Lackluster Year for Pfizer Amid Patent Expirations Impacting 2026 Forecast
Dec 15 2025
Benzinga
Adaptive Biotechnologies Partners with Pfizer on $890 Million TCR Agreement
Dec 15 2025
Newsfilter
Adaptive Biotechnologies to Discuss MRD Technology at Jefferies Fireside Chat
Dec 09 2025
Globenewswire
Adaptive Biotechnologies to Discuss MRD Technology at Jefferies Fireside Chat
Dec 09 2025
Newsfilter
Show More News
